As Pfizer (PFE) Shares Declined, Wade G W & Lowered Its Holding; Amazon Com (AMZN) Shareholder Gruss & Co Has Trimmed Holding by $4.03 Million as Shares Rose

May 24, 2018 - By Jacob Smith

Pfizer Inc. (NYSE:PFE) Logo

Gruss & Co Inc decreased its stake in Amazon Com Inc (AMZN) by 20.78% based on its latest 2017Q4 regulatory filing with the SEC. Gruss & Co Inc sold 3,450 shares as the company’s stock rose 28.13% while stock markets declined. The institutional investor held 13,150 shares of the consumer services company at the end of 2017Q4, valued at $15.38 million, down from 16,600 at the end of the previous reported quarter. Gruss & Co Inc who had been investing in Amazon Com Inc for a number of months, seems to be less bullish one the $777.85B market cap company. The stock increased 0.08% or $1.21 during the last trading session, reaching $1603.07. About 3.23 million shares traded. Amazon.com, Inc. (NASDAQ:AMZN) has risen 76.78% since May 24, 2017 and is uptrending. It has outperformed by 65.23% the S&P500.

Wade G W & Inc decreased its stake in Pfizer Inc (PFE) by 18.84% based on its latest 2017Q4 regulatory filing with the SEC. Wade G W & Inc sold 10,172 shares as the company’s stock declined 3.13% with the market. The institutional investor held 43,830 shares of the health care company at the end of 2017Q4, valued at $1.59 million, down from 54,002 at the end of the previous reported quarter. Wade G W & Inc who had been investing in Pfizer Inc for a number of months, seems to be less bullish one the $209.88 billion market cap company. The stock decreased 0.25% or $0.09 during the last trading session, reaching $35.88. About 12.81M shares traded. Pfizer Inc. (NYSE:PFE) has risen 2.43% since May 24, 2017 and is uptrending. It has underperformed by 9.12% the S&P500.

Since December 15, 2017, it had 0 insider purchases, and 13 insider sales for $17.75 million activity. Dolsten Mikael also sold $2.55M worth of Pfizer Inc. (NYSE:PFE) on Friday, March 9. $1.52 million worth of Pfizer Inc. (NYSE:PFE) shares were sold by HILL CHARLES H. Shares for $4.76M were sold by READ IAN C. 1,758 shares were sold by CORNWELL W DON, worth $64,679 on Monday, February 26. 6,750 Pfizer Inc. (NYSE:PFE) shares with value of $249,750 were sold by MACKENZIE ALEXANDER R. LUND-JURGENSEN KIRSTEN sold $353,677 worth of Pfizer Inc. (NYSE:PFE) on Saturday, February 24.

Wade G W & Inc, which manages about $4.63 billion and $870.98 million US Long portfolio, upped its stake in United Technologies Corp (NYSE:UTX) by 3,880 shares to 92,949 shares, valued at $11.86M in 2017Q4, according to the filing. It also increased its holding in Wisdomtree Tr (DON) by 76,422 shares in the quarter, for a total of 108,363 shares, and has risen its stake in Wisdomtree Tr (DLN).

Investors sentiment increased to 1.06 in 2017 Q4. Its up 0.10, from 0.96 in 2017Q3. It is positive, as 51 investors sold PFE shares while 675 reduced holdings. 134 funds opened positions while 632 raised stakes. 4.07 billion shares or 0.28% more from 4.06 billion shares in 2017Q3 were reported. 123,352 were reported by Marshwinds Advisory. Foundation Resource Management holds 1.26 million shares or 8.19% of its portfolio. Chase Investment Counsel Corporation invested in 0.14% or 7,175 shares. Stellar Cap Management Ltd Liability Co accumulated 12,669 shares. Ameriprise Inc holds 60.31 million shares. 1.50 million were reported by Research Global Invsts. Essex Fincl Serv holds 2.88% or 335,039 shares. Alliancebernstein Lp stated it has 20.07M shares. Meritage Port holds 0.47% or 134,278 shares. Moreover, Stadion Money Mgmt Ltd Limited Liability Company has 0.06% invested in Pfizer Inc. (NYSE:PFE) for 50,782 shares. Sg Americas Ltd accumulated 1.19 million shares. Creative Planning reported 772,677 shares stake. Shelter Mutual holds 239,800 shares or 2.59% of its portfolio. Moreover, Silvercrest Asset Grp Inc Llc has 1.1% invested in Pfizer Inc. (NYSE:PFE) for 3.27 million shares. Eastern Bankshares has 144,223 shares.

More notable recent Pfizer Inc. (NYSE:PFE) news were published by: 247Wallst.com which released: “How Much Pfizer Earnings Depend on a Few Brands” on May 01, 2018, also Streetinsider.com with their article: “Pfizer (PFE) Begins a Phase 1/2 Study to Evaluate RSV Vaccine” published on May 22, 2018, Seekingalpha.com published: “Pfizer: Buy This Dip?” on May 03, 2018. More interesting news about Pfizer Inc. (NYSE:PFE) were released by: Streetinsider.com and their article: “Pfizer (PFE) Says FDA Granted Breakthrough Therapy Designation for Tafamidis for Treatment of Patients with …” published on May 23, 2018 as well as 247Wallst.com‘s news article titled: “What to Look For in the Merck and Pfizer Reports Tuesday Morning” with publication date: April 30, 2018.

Analysts await Pfizer Inc. (NYSE:PFE) to report earnings on August, 7. They expect $0.75 EPS, up 11.94% or $0.08 from last year’s $0.67 per share. PFE’s profit will be $4.39 billion for 11.96 P/E if the $0.75 EPS becomes a reality. After $0.77 actual EPS reported by Pfizer Inc. for the previous quarter, Wall Street now forecasts -2.60% negative EPS growth.

Among 22 analysts covering Pfizer (NYSE:PFE), 9 have Buy rating, 1 Sell and 12 Hold. Therefore 41% are positive. Pfizer had 79 analyst reports since July 29, 2015 according to SRatingsIntel. The stock of Pfizer Inc. (NYSE:PFE) earned “Buy” rating by Deutsche Bank on Wednesday, October 28. The stock of Pfizer Inc. (NYSE:PFE) has “Buy” rating given on Wednesday, November 1 by UBS. On Friday, December 15 the stock rating was maintained by BMO Capital Markets with “Buy”. The firm earned “Neutral” rating on Monday, April 18 by Goldman Sachs. Credit Suisse downgraded the stock to “Neutral” rating in Thursday, July 20 report. The stock has “Overweight” rating by Morgan Stanley on Wednesday, January 31. The firm earned “Buy” rating on Tuesday, September 13 by Jefferies. The rating was maintained by Jefferies with “Hold” on Friday, April 13. The stock of Pfizer Inc. (NYSE:PFE) earned “Overweight” rating by Piper Jaffray on Friday, August 28. The rating was maintained by Argus Research with “Buy” on Wednesday, July 29.

Analysts await Amazon.com, Inc. (NASDAQ:AMZN) to report earnings on July, 26. They expect $2.42 earnings per share, up 505.00% or $2.02 from last year’s $0.4 per share. AMZN’s profit will be $1.17B for 165.61 P/E if the $2.42 EPS becomes a reality. After $3.27 actual earnings per share reported by Amazon.com, Inc. for the previous quarter, Wall Street now forecasts -25.99% negative EPS growth.

Since December 7, 2017, it had 0 insider purchases, and 21 selling transactions for $64.49 million activity. $2.99 million worth of Amazon.com, Inc. (NASDAQ:AMZN) was sold by WILKE JEFFREY A. $3.23M worth of Amazon.com, Inc. (NASDAQ:AMZN) shares were sold by Blackburn Jeffrey M. Shares for $2.72M were sold by Jassy Andrew R on Tuesday, May 15. Reynolds Shelley sold 544 shares worth $795,502. 1,375 Amazon.com, Inc. (NASDAQ:AMZN) shares with value of $2.17M were sold by STONESIFER PATRICIA Q. 2,216 Amazon.com, Inc. (NASDAQ:AMZN) shares with value of $3.24M were sold by Zapolsky David.

More notable recent Amazon.com, Inc. (NASDAQ:AMZN) news were published by: Seekingalpha.com which released: “Is Netflix Uninvestable? 2 Insiders Weigh In” on May 24, 2018, also Seekingalpha.com with their article: “Amazon’s AWS: The Land Of Milk And Honey” published on May 21, 2018, Investorplace.com published: “20 Stocks Hedge Fund Managers Are Buying In Bulk” on May 23, 2018. More interesting news about Amazon.com, Inc. (NASDAQ:AMZN) were released by: Seekingalpha.com and their article: “Amazon’s Advertising Business: An Emerging Giant” published on May 21, 2018 as well as Seekingalpha.com‘s news article titled: “Pentagon explains single winner for cloud contract” with publication date: May 14, 2018.

Investors sentiment increased to 1.29 in 2017 Q4. Its up 0.03, from 1.26 in 2017Q3. It increased, as 69 investors sold AMZN shares while 578 reduced holdings. 168 funds opened positions while 667 raised stakes. 280.02 million shares or 0.09% more from 279.77 million shares in 2017Q3 were reported. Thrivent Fin For Lutherans owns 2.14% invested in Amazon.com, Inc. (NASDAQ:AMZN) for 545,655 shares. Synovus Fin Corporation holds 0.34% of its portfolio in Amazon.com, Inc. (NASDAQ:AMZN) for 16,831 shares. Massachusetts-based East Coast Asset Mngmt Ltd Liability Co has invested 7.92% in Amazon.com, Inc. (NASDAQ:AMZN). Gamco Et Al reported 4,252 shares. Tobam holds 0.09% or 1,695 shares. Weiss Multi has invested 0.17% in Amazon.com, Inc. (NASDAQ:AMZN). Nomura Asset Management Limited accumulated 145,447 shares. Appleton Prtnrs Ma accumulated 1.37% or 7,530 shares. City Hldg holds 0.46% or 1,236 shares in its portfolio. Hhr Asset Management Ltd Limited Liability Company stated it has 4.09% of its portfolio in Amazon.com, Inc. (NASDAQ:AMZN). 47 were accumulated by Mcf Advsr Ltd Com. Hallmark Capital Mgmt stated it has 0.09% of its portfolio in Amazon.com, Inc. (NASDAQ:AMZN). Enterprise Financial Service holds 0.23% of its portfolio in Amazon.com, Inc. (NASDAQ:AMZN) for 409 shares. Vision Cap Inc reported 9,929 shares. Glg Ltd Liability Company accumulated 20,146 shares or 1.69% of the stock.

Among 55 analysts covering Amazon.com (NASDAQ:AMZN), 52 have Buy rating, 0 Sell and 3 Hold. Therefore 95% are positive. Amazon.com had 302 analyst reports since July 21, 2015 according to SRatingsIntel. Wells Fargo maintained Amazon.com, Inc. (NASDAQ:AMZN) rating on Friday, October 27. Wells Fargo has “Buy” rating and $1430.0 target. Credit Suisse maintained Amazon.com, Inc. (NASDAQ:AMZN) on Wednesday, January 11 with “Outperform” rating. The stock of Amazon.com, Inc. (NASDAQ:AMZN) earned “Buy” rating by Cowen & Co on Tuesday, February 27. The firm has “Overweight” rating by Barclays Capital given on Friday, April 27. On Thursday, March 15 the stock rating was maintained by Wells Fargo with “Buy”. As per Friday, June 16, the company rating was maintained by Oppenheimer. The firm has “Buy” rating by Morgan Stanley given on Friday, July 28. The stock of Amazon.com, Inc. (NASDAQ:AMZN) has “Buy” rating given on Friday, March 9 by Evercore. On Thursday, April 7 the stock rating was maintained by JP Morgan with “Overweight”. Robert W. Baird maintained it with “Buy” rating and $1100.0 target in Tuesday, August 29 report.

Pfizer Inc. (NYSE:PFE) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts

>